Key facts
- Notable investors include Tianjin Binhai Industrial Fund Management, Xiangtai Venture Capital, Xingtuo Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for GloryMed-Ai
- ·The full record, as it builds
Funding rounds
No funding rounds for GloryMed-Ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GloryMed-Ai
Manufacturer of medical imaging and diagnostic devices designed to enhance the detection and analysis of gastrointestinal diseases. The company offers AI-powered endoscopy workstations, microendoscopy probes, 3D gut modelling systems, and edible gastric sensors, incorporating deep learning and high-precision imaging, enabling hospitals and clinical endoscopy centres to improve diagnostic accuracy, streamline procedures, and enhance quality control.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2018
- Website
- endosmart.cn/
- Ownership
- Privately Held (backing)
GloryMed-Ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GloryMed-Ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GloryMed-Ai in its N-PORT filings yet. We sweep new filings monthly.